Charlotte, NC — A study released this week in the American Heart Association’s (AHA) publication Circulation found that young patients who experienced myocarditis were overwhelmingly injected with an experimental mRNA COVID-19 shot within a month of the heart condition starting. The study looked at data on 139 adolescent or young adult patients, all under 21 years old, “with suspected myocarditis within 30 days of COVID-19 vaccination” from 26 healthcare centers in America. The study states: “Understanding the clinical course and short-term outcomes of suspected myocarditis following COVID-19 vaccination has important public health implications in the decision to vaccinate youth.” It...
